Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Dutasteride and finasteride affect different cell types differently.

5α-reductase inhibitors help shrink the prostate, improve urinary symptoms, and may reduce prostate cancer risk.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Post-finasteride syndrome causes lasting sexual, mental, and physical issues, needing more research for solutions.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

Seaweeds have beneficial compounds for skin care, including anti-aging and protective effects.

A new gene, JMJD1C, may affect testosterone levels in men.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.